Announcements Trials
Browse Landscape

Status

Completed 75Recruiting 28Terminated 24Unknown 21Withdrawn 13Active not recruiting 12Not yet recruiting 7No longer available 1Enrolling by invitation 1Available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Breast Neoplasms 7Triple Negative Breast Neoplasms 4Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms by Site 1Neoplasms 1Metastatic gpNMB Expressing Triple Negative Breast Cancer 1Melanoma 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Diseases 1Brain Neoplasms 1Advanced Breast Cancer (Female) 1

Interventions

tucatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × Brain Neoplasms × Breast × Clear all
NCT03424473 2020-02-25

Expanded Access Use of Tucatinib for HER2+ Metastatic Breast Cancer

Seagen Inc.

No longer available
BreastCNS

Brain Neoplasms, Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site

Data powered by HemOnc (CC BY 4.0) Colophon âš¡